Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06116552 · ClinicalTrials.gov registry record · NA

More and Less Social Comprehension

A NA study of Autism Spectrum Disorder, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06116552: Recruiting NA study of Autism Spectrum Disorder, sponsored by University of Kansas Medical Center.

NCT06116552 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 50 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06116552, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this early Phase 1 clinical trial is to assess if the social content of a story impacts autistic children's listening comprehension of stories. The main questions this study aims to answer are: * Does removing social content from a story improve listening comprehension in autistic children? * Does listening comprehension of more social versus less social stories differentially predict performance on a standardized reading comprehension measure? Participants will listen to more social and less social stories while viewing accompanying pictures and answer comprehension questions about the stories and complete a standardized assessment of reading comprehension. In addition, participants complete measures of their nonverbal cognition, hearing status, autism severity, language abilities, and social communication abilities to help characterize individual differences in participants.

Primary Outcome

The Socialness Story Comprehension Task assesses listening comprehension of more and less social stories. Participants listen to stories while looking at picture scenes and then answer three open-ended comprehension questions about each story. The participant is presented with two practice stories first, and then eight main stories. One practice story and four of the main stories are more social. Comprehension questions are scored as correct or incorrect. Participant scores may range from 0% (0

Conditions Studied

Interventions

  • BEHAVIORAL More Social Stories
  • BEHAVIORAL Less Social Stories

Study Locations (1)

Kansas

  • University of Kansas Comprehension and Language Learning Lab - Lawrence

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-07-10
Est. Completion 2025-12
Phase NA
University of Kansas Medical Center

408 total trials

What NCT06116552 shows while recruiting

NCT06116552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which More Social Stories is the first listed.

NCT06116552 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT06116552 about?

NCT06116552 is a clinical study titled "More and Less Social Comprehension". The goal of this early Phase 1 clinical trial is to assess if the social content of a story impacts autistic children's listening comprehension of stories. The main questions this study aims to answer are: * Does removing social content from a story improve listening comprehension in autistic child...

What is the current status of trial NCT06116552?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-07-10. Estimated completion is 2025-12.

What conditions does trial NCT06116552 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT06116552?

The interventions under investigation include: More Social Stories (BEHAVIORAL), Less Social Stories (BEHAVIORAL).

Who is sponsoring clinical trial NCT06116552?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06116552 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06116552's enrollment target sits among peer trials

50 141st of 224 higher than 79 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06116552, the US trial registry maintained by the National Library of Medicine. NCT06116552 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.